Vascular News and Research

RSS

Sugary foods may affect recovery from heart attack

Scientists at the University of Leicester have demonstrated for the first time the mechanism by which the level of sugar in your blood can affect the contraction of blood vessels, with potentially dangerous effects on the heart and blood pressure.

8 Jan 2016

AngioDefender holds much promise for personalized cardiac care

For a non-descript box it wields a mighty name and even more impressive possibilities for people with heart disease. Called the AngioDefender, the machine - no bigger than a shoebox - holds much promise in the ability to personalize cardiac care, say researchers at Lawson Health Research Institute, the research arm of St. Joseph's Health Care London.

8 Jan 2016

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

To determine patient eligibility for heart transplant, the International Society for Heart Lung Transplantation maintains a list of criteria, first issued in 2006, that acts as a guideline for physicians.

7 Jan 2016

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announce today the release of the initial results from the first-in-human study of its unique drug-coated balloon, Chocolate Heart.

7 Jan 2016

CUMC study reveals statins may help reduce heart disease risk in people with sleep apnea

A new study conducted at Columbia University Medical Center has revealed some of the underlying mechanisms that may increase the risk of heart disease in people with sleep apnea. The study also found that statins -- the cholesterol-lowering medications commonly prescribed to combat heart disease -- may help reverse this process.

7 Jan 2016

Scientists develop a method for cell replacement in diseased vessels

In industrialized countries, a particularly high number of people suffer from arteriosclerosis -- with fatal consequences: Deposits in the arteries lead to strokes and heart attacks. A team of researchers under the leadership of the University of Bonn has now developed a method for guiding replacement cells to diseased vascular segments using nanoparticles.

7 Jan 2016

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Argon Medical Devices, Inc. announced the completed acquisition of three vascular products from Rex Medical, LLC. The OptionELITE Retrievable Vena Cava Filter, CLEANER Rotational Thrombectomy System, and UltraStream Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc.

5 Jan 2016

Infusing small dose of cytokine can prevent or reverse diabetes-related kidney failure

Diabetes is the leading cause of kidney failure, and scientists have found that infusing just a small dose of a cytokine, thought to help cause that failure, can instead prevent or reverse it.

29 Dec 2015

Penn study explores bleeding complications linked to cardiac stent placement techniques

More than 375,000 American each year experience a heart attack, during which blood flow to a part of the heart is impeded by blocked arteries. Physicians often treat patients with stents, which prop open the arteries to allow blood to flow again. They use two approaches to place stents: transradial, or entry of the catheter which delivers the stent through the wrist, or transfemoral, in which the catheter is placed through the groin.

23 Dec 2015

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an investigational therapy in patients with previously treated EGFR mutant-positive non-small cell lung cancer.

23 Dec 2015

Commonly used diabetes drug may have potential to prevent, treat preeclampsia

An article published today in the American Journal of Obstetrics and Gynecology reports that a commonly-used drug for the treatment of diabetes, metformin, may have the potential to prevent and treat preeclampsia. Metformin has long been used to treat diabetes in both non-pregnant and pregnant patients, and is considered safe during pregnancy.

22 Dec 2015

Scientists identify 52 genetic variations associated with age-related macular degeneration

In one of the latest examples of precision medicine, teams of geneticists from nine countries, involving more than 100 scientists, analyzed the genes of more than 33,000 individuals in the hope of finding genetic variations responsible for age-related macular degeneration (AMD), the leading cause of vision loss among people age 50 or older.

22 Dec 2015

Small airway-on-a-chip enables analysis of human COPD and asthma

A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.

22 Dec 2015

Dietary cocoa flavanols may benefit cardiovascular health of patients with poor kidney function

Consuming a beverage containing cocoa flavanols improves blood vessel function in patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

21 Dec 2015

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.

18 Dec 2015

One of every three deaths in the U.S. linked to cardiovascular diseases

One of every three deaths in the U.S. in 2013 were from heart disease, stroke and other cardiovascular diseases, while heart disease and stroke were the No. 1 and No. 2 killers worldwide, according to American Heart Association's 2016 Heart Disease and Stroke Statistics Update.

17 Dec 2015

Anemia associated with increased risk of mild cognitive impairment

In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin <13 g/dl in men and <12 g/dl in women, showed lower performances in verbal memory and executive functions.

17 Dec 2015

Study sheds new light on the causes of autism

Evidence of autism may be found in the composition and malfunction of the brain's blood vessels, a team of scientists has found. Their research sheds new light on the causes of autism, which previously had pointed to neurological make-up rather than to the vascular system, and identifies a new target for potential therapeutic intervention.

17 Dec 2015

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Two innovative Oxford research programmes will explore the relationship between metabolism and inflammation in metabolic diseases. Obesity, insulin resistance, type 2 diabetes (T2D) and associated cardiovascular disease (CVD) -- all metabolic diseases -- are an epidemic global health problem.

17 Dec 2015

Major clinical trial launched to test ways to slow or halt mental decline in seniors

Some decline in memory and cognitive function is a normal part of aging, but what if it could be prevented? Researchers at University of California, San Diego School of Medicine and Washington University in St. Louis have launched a major clinical trial to investigate whether mental decline in seniors can be slowed or halted through exercise and other health-related interventions.

16 Dec 2015

Vascular News and Research

Sugary foods may affect recovery from heart attack

AngioDefender holds much promise for personalized cardiac care

ISHLT issues new list of criteria to determine patient eligibility for heart transplant

QT Vascular reports initial results from first-in-human study of Chocolate Heart drug-coated balloon

CUMC study reveals statins may help reduce heart disease risk in people with sleep apnea

Scientists develop a method for cell replacement in diseased vessels

Argon Medical Devices completes acquisition of three vascular products from Rex Medical

Infusing small dose of cytokine can prevent or reverse diabetes-related kidney failure

Penn study explores bleeding complications linked to cardiac stent placement techniques

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

Commonly used diabetes drug may have potential to prevent, treat preeclampsia

Scientists identify 52 genetic variations associated with age-related macular degeneration

Small airway-on-a-chip enables analysis of human COPD and asthma

Dietary cocoa flavanols may benefit cardiovascular health of patients with poor kidney function

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

One of every three deaths in the U.S. linked to cardiovascular diseases

Anemia associated with increased risk of mild cognitive impairment

Study sheds new light on the causes of autism

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Major clinical trial launched to test ways to slow or halt mental decline in seniors

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News